Business & Finance
Sontra Medical Corporation regains compliance with Nasdaq's minimum bid price requirement
Published in Drug Week, October 6th, 2006
On August 11, 2006, Sontra completed a 1-for-10 reverse split of its common stock and since that date the company's common stock was traded under the current symbol SONTD. Following compliance, the company's common stock will trade once again under the symbol SONT.
Sontra Medical Corporation is focused on transdermal science and is developing a noninvasive, continuous transdermal glucose monitor (CTGM) for principal use in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-10-06)
More Articles from Drug Week
- Antibacterial Agents
C12 ethyl ketolides with antibacterial activity have been synthesized - Attention Deficit Hyperactivity Disorder
Structure of stable and meta-stable forms of atomoxetine are described - Breast Cancer
Introgen's Advexin therapy shows promise in the treatment of breast cancer - Crohn Disease
Abbott submits U.S., E.U. regulatory applications for Humira for Crohn disease - HIV/AIDS Drug Development
Tricyclic HIV-1 integrase inhibitors developed - AAT Deficiency
Extensive post-license data reaffirm clinical safety profile of Prolastin - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
